TerminatedNCT02757521
Nitrous TRD Depression in bipolarity
Medication studyAges 18–75United States
Understand this study
Who could participate?
Listed age limits: 18 years to 75 years.
- Listed locations
- St LouisSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 25, 2016
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 1
- Sponsor
- Washington University School of Medicine
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT02757521
- Official title
Show the full official title
Nitrous Oxide - A Novel Therapy for Treatment-Resistant Bipolar Depression
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
St Louis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Washington University School of Medicine, a university.
Does this study involve medication?
Yes. The study involves medication, including Nitrous Oxide and Placebo.
Who can participate?
Listed age limits: 18 years to 75 years.
Is this study still recruiting?
The registry lists this study as terminated.
